Evidence map›Paper›PMID 42899061›Full record

ReviewFrontiers in bioengineering and biotechnology2026

A review of 3D In vitro skin models for psoriasis: from pathophysiology to advanced bioengineering.

Yuying Cheng, Feifei Wang, Bo Wang

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuying ChengYunnan Botanee Bio-technology Group Co., Ltd., Yunnan, China.
Feifei WangYunnan Botanee Bio-technology Group Co., Ltd., Yunnan, China.
Bo WangYunnan Botanee Bio-technology Group Co., Ltd., Yunnan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three-dimensional (3D) skin models have become a transformative choice for replacing animal models in psoriasis research. However, the diversity of platforms, from commercial skin equivalents to organ-on-a-chip systems, has rapidly increased, posing a key selection dilemma for researchers. Based on this, we comprehensively classified the models based on their construction strategies and compared their pathological fidelity from six key dimensions: structural complexity, immune integration, vascular or neural function, scalability, primary application and recommended biological composition. Looking back at the development process of

Indexed as

3D bioprinting3D skin modelin vitro modelingorgan-on-a-chippsoriasis

Identifiers

PMID42899061
PMCPMC13678526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.